| 000 | 01769 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515075512.0 | ||
| 264 | 0 | _c20070827 | |
| 008 | 200708s 0 0 eng d | ||
| 022 | _a1545-9616 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBoguniewicz, Mark | |
| 245 | 0 | 0 |
_aA multiple-domain framework of clinical, economic, and patient-reported outcomes for evaluating benefits of intervention in atopic dermatitis. _h[electronic resource] |
| 260 |
_bJournal of drugs in dermatology : JDD _cApr 2007 |
||
| 300 |
_a416-23 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Topical |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aCost of Illness |
| 650 | 0 | 4 |
_aDermatitis, Atopic _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNonprescription Drugs _xeconomics |
| 650 | 0 | 4 | _aOintments |
| 650 | 0 | 4 |
_aPatient Compliance _xstatistics & numerical data |
| 650 | 0 | 4 |
_aPatient Dropouts _xstatistics & numerical data |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 |
_aTacrolimus _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aAbramovits, William | |
| 700 | 1 | _aPaller, Amy | |
| 700 | 1 | _aWhitaker-Worth, Diane L | |
| 700 | 1 | _aPrendergast, Mary | |
| 700 | 1 | _aCheng, J Wang | |
| 700 | 1 | _aWang, Patrick | |
| 700 | 1 | _aTong, Kuo B | |
| 773 | 0 |
_tJournal of drugs in dermatology : JDD _gvol. 6 _gno. 4 _gp. 416-23 |
|
| 999 |
_c17201361 _d17201361 |
||